Molecular Epidemiology of Charcot-Marie-Tooth Disease in Northern Ostrobothnia, Finland: A Population-Based Study
Conclusions: The prevalence of CMT in Northern Ostrobothnia, Finland, seems to be slightly higher than those in previous studies in European populations. Founder mutation in theGDAP1 gene accounts for a large part of the genetically defined CMT2 in Finland.Neuroepidemiology 2017;49:34-39
Source: Neuroepidemiology - Category: Epidemiology Source Type: research
More News: Brain | Charcot-Marie-Tooth Disease | Epidemiology | Finland Health | Genetics | Neurology | Peripheral Neuropathy | Study